Source:http://linkedlifedata.com/resource/pubmed/id/19874430
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2010-6-3
|
| pubmed:abstractText |
As psoriatic disease (PD) is a condition characterized by the combination of inflammatory skin (psoriasis) and osteo-articular manifestations (psoriatic arthritis), its treatment should cover both its clinical components.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
1468-3083
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
24
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
578-86
|
| pubmed:meshHeading | |
| pubmed:year |
2010
|
| pubmed:articleTitle |
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease.
|
| pubmed:affiliation |
UOC DH of Rheumatology, G. Pini Orthopaedic Institute, Milan, Italy. marchesoni@gpini.it
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|